Publications by authors named "Michael Lux"

Claim this Profile
R
Real-world 12-month outcomes of repeated high-concentration capsaicin patch in chemotherapy-induced peripheral neuropathy: results from the CASPAR study.
Michael A Überall, Rainer Sabatowski, Michael Patrick Lux, Myriam Heine, Lucia Garcia Guerra

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.
Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber, Michael Braun, Peter A Fasching, Michael P Lux

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, Nina Ditsch, Tanja Fehm, Michael Patrick Lux

Eur J Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges.
Mark Verrill, Michael Patrick Lux, Joseph Gligorov, Jürgen Geisler, Renata Duchnowska

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).
Steffi Hartmann, Maggie Banys-Paluchowski, Tomasz Berger, Nina Ditsch, Elmar Stickeler, Michael Patrick Lux

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Laura L Michel, Philipp Ziegler, Philipp Kreis, Andreas D Hartkopf, Markus Wallwiener, Michael P Lux

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.
Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch, Elmar Stickeler, Michael Hauptmann, Michael Patrick Lux

Br J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial.
Rosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, Jana de Boniface, Esther Schmidt, Michael Patrick Lux

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study.
Sebastian Daniel Boie, Esther Glastetter, Michael Patrick Lux, Felix Balzer, Christof von Kalle

JMIR Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness of genomic testing among patients with breast cancer in Europe.
Antonella Cardone, Dany Bell, Conchi Biurrun, Francesco Cognetti, Fatima Cardoso, Michael Patrick Lux

Breast· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast Cancer.
Wolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau, Michael P Lux

Geburtshilfe Frauenheilkd· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast Cancer.
Diana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau, Michael P Lux

Geburtshilfe Frauenheilkd· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-Operation Rate for Breast Conserving Surgery Using Confocal Histolog Scanner for Intraoperative Margin Assessment-SHIELD Study.
Michael P Lux, Zlatna Schuller, Sara Heimann, Verena M C Reichert, Christian Kersting

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer.
Christina B Walter, Andreas D Hartkopf, Alexander Hein, Peter A Fasching, Hans-Christian Kolberg, Michael P Lux

Breast· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025.
Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Michael Patrick Lux

Breast Care (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025.
Marc Thill, Wolfgang Janni, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Michael Patrick Lux

Breast Care (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype.
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, Lothar Häberle, Hans-Christian Kolberg, Michael P Lux

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer.
Eugen Ruckhäberle, Marcus Schmidt, Anja Welt, Nadia Harbeck, Achim Wöckel, Michael P Lux

Geburtshilfe Frauenheilkd· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients - results of the QUCIP study.
Michael Patrick Lux, Lilit Flöther, Catrin Frömter, Brigitte Rack, Kristina Veselinovic

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
Peter A Fasching, Chunling Hu, Steven N Hart, Matthias Ruebner, Eric C Polley, Michael P Lux

NPJ Breast Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer.
Rachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau, Michael P Lux

Geburtshilfe Frauenheilkd· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024.
Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys Paluchowski, Ingo Bauerfeind, Michael Patrick Lux

Breast Care (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.
Marc Thill, Wolfgang Janni, Ute-Susann Albert, Maggie Banys-Paluchowski, Ingo Bauerfeind, Michael Patrick Lux

Breast Care (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry.
Andreas D Hartkopf, Christina B Walter, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Michael P Lux

Geburtshilfe Frauenheilkd· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs.
Andreas Schneeweiss, Sara Y Brucker, Hanna Huebner, Lea L Volmer, Carolin C Hack, Michael P Lux

Geburtshilfe Frauenheilkd· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis